HIF-1 as a target for drug development
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Sensing and responding to fluxes in oxygen tension is perhaps the single most important variable in physiology, and animal tissues have developed a number of essential mechanisms to cope with the stress of low physiological oxygen levels, or hypoxia. Among these coping mechanisms is the response mediated by the hypoxia-inducible transcription factor, or HIF-1. HIF-1 is an essential component in changing the transcriptional repertoire of tissues as oxygen levels drop, and could prove to be a very important target for drug development, as treatments evolve for diseases, such as cancer, heart disease and stroke, in which hypoxia is a central aspect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, growing evidence showed that the strong cell–cell contacts of tumor spheroids in combination with dense ECM deposition is responsible for chemoresistance by posing a physical barrier to the penetration of chemotherapeutics and immune cells similar to in vivo.[ 48 ]”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [48]
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“Most importantly, overexpression of HIF-1α or HIF-2α have been implicated as poor prognostic indicators for a variety of tumour”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476 · cited 1×
“Although the role of HIF-1α in human tumours remains correlative, in transplanted tumours in immunodeficient mice, loss of HIF-1α or HIF-1β results in reduced tumour growth, decreased angiogenesis and increased responsiveness to radiotherap”
BackgroundHuang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Research works printed but not linked: 1
- Flamme, I., Frolich, T. & Risau, W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell. Physiol. 173, 206–210 (1997). · DOI · Paper page
Cited by
Items 601–671 of 671
Characterisation of the in vitro effects of Asiatic acid in Glioblastoma
Thakor, F. K. (2016) · CLOK (University of Central Lancashire)
Leung, E. (2011) · TSpace (University of Toronto)
The Clinical Impact of Hypoxia in Head and Neck Squamous Cell Carcinoma
Lim, A. M. L., Le, Q., & Rischin, D. (2018) · Current cancer research · doi:10.1007/978-3-319-78762-6_15
ОБҐРУНТУВАННЯ НЕОБХІДНОСТІ ВИВЧЕННЯ МОЛЕКУЛЯРНОЇ БІОЛОГІЇ В МЕДИЧНИХ УНІВЕРСИТЕТАХ
Minchenko, О. H., Minchenko, D. O., & Korda, M. M. (2020) · Медична освіта · doi:10.11603/me.2414-5998.2019.4.10861
Histological Changes in the Duodenum of Mice Treated with Cobalt
Gathwan, K. H., Albir, A. A., & Saadi, A. H. A. (2013) · Iraqi Journal of Science
Rogers, K. E. (2006) · UA Campus Repository (The University of Arizona)
Shah, S. (2010) · Digital Repository Service (Northeastern University) · doi:10.17760/d20000811
Manipulation of hypoxia-inducible factor-1? transactivation by mutation of C-TAD residues
null (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.2.257
“Conversely, HIF-1 inhibition in solid tumours is an attractive anticancer treatment [6,7].”
BackgroundPatel, J. (2012) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2012-06872
Hypoxia in Head and Neck Cancers: Clinical Relevance and Treatment
Tao, Y., & Bourhis, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-27601-4_12
Kong, D., Park, E., Stephen, A. G., Calvani, M., Cardellina, J. H., Monks, A. P., Fisher, R. J., Shoemaker, R. H., & Melillo, G. (2023) · doi:10.1158/0008-5472.22365320
Smith, K., Gunaratnam, L., Morley, M., Franovic, A., Mekhail, K., & Lee, S. (2023) · doi:10.1158/0008-5472.c.6493911.v1
Dang, D. T., Chun, S. Y., Burkitt, K., Abe, M., Chen, S. W., Havre, P. A., Mabjeesh, N. J., Heath, E. I., Vogelzang, N. J., Cruz-Correa, M. R., et al. (2023) · doi:10.1158/0008-5472.c.6497498
Smith, K., Gunaratnam, L., Morley, M., Franovic, A., Mekhail, K., & Lee, S. (2023) · doi:10.1158/0008-5472.c.6493911
Data from Identification of a Novel Small Molecule HIF-1α Translation Inhibitor
Narita, T., Yin, S., Gelin, C. F., Moreno, C. S., Yepes, M., Nicolaou, K. C., & Meir, E. G. V. (2023) · doi:10.1158/1078-0432.c.6517576.v1
Comparative and population genomics analyses of eared pheasants inhabiting highly varying altitudes
Wu, S., Wang, K., Ge, X., Yuan, S., Wu, D., Ge, C., Jia, J., Su, Z., & Dou, T. (2026) · BMC Genomics · doi:10.1186/s12864-026-12998-z
Febrônio, E. M. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2024.tde-26072024-142849
Role of tissue hypoxia in periodontitis
Li, J. (2011) · The HKU Scholars Hub (University of Hong Kong) · doi:10.5353/th_b4784956
曹小年, Wu, W., Wang, D., Sun, W., & 来森艳 (2022) · Figshare · doi:10.6084/m9.figshare.19367327
He, F., Xiao, H., Cai, Y., & Zhang, N. (2021) · Figshare · doi:10.6084/m9.figshare.14583499
Metabolic Alterations in Colorectal Polyps and their Role in Carcinogenesis
Rebane-Klemm, E. (2023) · TUTL Collection · doi:10.23658/taltech.27/2023
Maxeiner, S. (2018) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-152759
He, F., Xiao, H., Cai, Y., & Zhang, N. (2021) · Figshare · doi:10.6084/m9.figshare.14583502
曹小年, Wu, W., Wang, D., Sun, W., & 来森艳 (2022) · Figshare · doi:10.6084/m9.figshare.19367324
He, C., Kong, S., Zhang, J., Chen, L., Zhang, G., Jin, L., Zhang, X., & Ding, B. (2026) · iScience · doi:10.1016/j.isci.2026.115359
“11 HIF-1 α -driven transcription of connective tissue growth factor (CTGF) and collagen I lead to the formation of a dense ECM, which further restricts nanomedicine penetration into the tumor parenchyma and thereby compromise antitumor efficacy.”
Influence of hypoxia on tumour cell susceptibility to cytotoxic T lymphocyte mediated lysis
Noman, M. Z. (2012) · theses.fr (ABES) · doi:10.70675/306da2eez5bc3z478ez83c5zdc39407a896e · Cited by 1
Guerrab, A. E. (2011) · theses.fr (ABES) · doi:10.70675/0680d6aez5ddfz48efzabe9zf58f93e15842
Conséquences de l'hypoxie sur la régulation de la signalisation HGF/SF-MET
Mekki, M. S. (2015) · theses.fr (ABES) · doi:10.70675/2c2b2ffez79f1z4cf8z803azfa7a863dac69
“… humains et de modèles expérimentaux chez l’animal, il devient de plus en plus clair que les HIFs jouent un rôle critique dans la progression cancéreuse (figure 21) (Giaccia et al 2003, Maxwell et al 2001, Semenza 2003).”
Celiński, R., Kocki, J., Grzywa-Celińska, A., Szewczyk, K. D. S., & Berecka-Rycerz, A. (2026) · Applied Sciences · doi:10.3390/app16104806
Glycolytic Reprogramming Mediated by the OTUD4-FXR1-HIF1A Axis Drives Gastric Cancer Progression
Wang, F., Shao, Y., Zhuang, X., Liu, X., Hu, Y., Dai, C., Chen, J., Kuang, Y., Wang, G., Zhao, Z., et al. (2026) · International Journal of Biological Sciences · doi:10.7150/ijbs.138384
“Its central role in cancer metabolism has therefore made HIF-1α an attractive therapeutic target [37].”
BindingDB (2011) · UC San Diego · doi:10.7270/q2hx1cxm
BindingDB Entry 50040848: Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
BindingDB (2013) · UC San Diego · doi:10.7270/q26d5v4n
BindingDB Entry 50015977: Cyclic Peptide Screening Methods for Preclinical Drug Discovery.
BindingDB (2023) · UC San Diego · doi:10.7270/q24q7zzw
BindingDB (2012) · UC San Diego · doi:10.7270/q2wd40xf
BindingDB Entry 50040555: The many faces of the adamantyl group in drug design.
BindingDB (2013) · UC San Diego · doi:10.7270/q22808qq
Integrative Pro-angiogenic Activation: HIF-α
Vincent, K. A., & Kelly, R. A. (2007) · Springer eBooks · doi:10.1007/1-4020-5955-8_7 · Cited by 2
Hypoxia and the Cardiac Lymphatic System
Wuest, T. R., & Lin, P. C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6774-8_10
Metadata
- Authors
- Giaccia, A., Siim, B. G., & Johnson, R. S.
- Affiliations
- Stanford Medicine (US)
- University of Auckland (NZ)
- University of California San Diego (US)
- Corresponding author
- Johnson, Randall S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-10-01
- Volume
- 2
- Issue
- 10
- Pages
- 803-811
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2075880922
- Cited by
- 631
- References
- 116
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 10 · 2023: 21 · 2022: 26 · 2021: 19 · 2020: 30 · 2019: 14 · 2018: 26 · 2017: 16 · 2016: 20 · 2015: 20 · 2014: 27 · 2013: 30 · 2012: 29
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- HIF-1, hypoxia-inducible factor, hypoxia, therapeutic target, oxygen sensing, transcriptional regulation, cancer, heart disease, stroke, therapeutic targeting
- MeSH terms
- Animals, Cardiovascular Diseases, DNA-Binding Proteins, Gene Expression Regulation, Humans, Neoplasms, Nuclear Proteins, Oxygen, Transcription Factors, Drug Design, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.